The independent source for health policy research, polling, and news.
6,501 - 6,520 of 15,227 Results
Republicans seek to turn the tables on charges that they are undermining preexisting conditions, so they’re hammering the plans championed by some Democrats to expand Medicare.
Although dialysis provider DaVita Inc. has taken major financial hits this year, including a $383.5 million jury award in response to wrongful death lawsuits, it still rakes in profits. The company faces its biggest threat next month, when California voters weigh in on a ballot initiative that could force it to leave the state.
A California college professor never imagined that trying to figure out what was causing her rash could add up to such a huge bill.
Union-backed initiatives in Palo Alto and Livermore, Calif., aim to cap charges by hospitals and doctors, seeking to build on national furor over rising medical bills. The measures arise in health care markets that are among the most expensive in the nation.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Over the past five months, the Trump administration has proposed a series of reforms to lower the cost of prescription drugs.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Idaho is one of four conservative states where voters next month will determine whether to buck the GOP’s resistance to the Affordable Care Act and implement or renew its expansion of Medicaid to adults.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Kimberly Leonard of the Washington Examiner and Alice Ollstein of Politico discuss a flurry of proposals from the Trump administration on prices Medicare pays for drugs and the Affordable Care Act.
Federal law guarantees that people have the right to see and obtain a copy of their medical records. But, hospitals, doctors, pharmacies and insurance companies often erect obstacles.
The drop in the number of people enrolled in the federal-state program for low-income residents is the first since 2007.
The state-federal health insurance program is more popular than ever. Now, states that want to expand eligibility are devising new strategies to pay for it — creating, in many red states, a significant political challenge.
Dialysis companies have contributed more than $110 million to defeat an initiative on California’s Nov. 6 ballot that would limit their profits — breaking the $109 million record set by the pharmaceutical industry in 2016.
The front-runner in the California governor’s race, known for his political audacity, has officially endorsed the controversial move to create one public insurance program for all Californians. Yet he also faces formidable challenges, and liberal critics fear he’ll retreat.
This gap in the 2010 health law means health insurance remains unaffordable for millions of Americans. For now, relief is hard to come by.
The new guidance allows states to ask for waivers from provisions in the Affordable Care Act governing not only subsidies, but also the benefits insurers must offer in all their plans.
As rates of sexually transmitted diseases surge, public health officials want physicians to step up screening and treatment of patients.
Candidates are charging toward midterm elections on a platform of single-payer and universal coverage rhetoric. Yet “Medicare-for-all” and single-payer mean different things to different people.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
This Facebook Live discussion explores an aspect of the health care cost continuum that often flies below the radar.
© 2026 KFF